Underdog Pharmaceuticals
Pharmaceutical
Founded in 11/1/19
Mountain View, California, United States
For Profit
About Underdog Pharmaceuticals
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 17519169 USD
- Last Funding: 10000000 USD (Seed)
- Funding Status: Seed
Technology Stack
Underdog Pharmaceuticals actively uses None products in their tech stack.
Market Presence
Industries: Pharmaceutical
Headquarters: Mountain View, California, United States